A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Gilteritinib d3 | CAS 2377109-67-4 - Request Quote

Picture of Gilteritinib d3

Gilteritinib d3

SZ CAT No:SZ-G023D01
CAS No
2377109-67-4
Mol.F.
C29H41D3N8O3
Mol.Wt.
555.7
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Gilteritinib d3 is chemically 6-Ethyl-3-((3-methoxy-4-(4-(4-(methyl-d3)piperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide. Gilteritinib d3 is supplied with detailed characterization data compliant with regulatory guideline. Gilteritinib d3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Gilteritinib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 2377109-67-4

Purchase 2377109-67-4

Order 2377109-67-4

Enquire 2377109-67-4

price of 2377109-67-4

2377109-67-4 Supplier

2377109-67-4 Manufacturer

2377109-67-4 Exporter

buy high quality Gilteritinib d3

Purchase Gilteritinib d3

Gilteritinib d3 suppliers

Gilteritinib d3 manufacturers

Gilteritinib d3 price

Order Gilteritinib d3

Enquire Gilteritinib d3

Gilteritinib d3 cost

Gilteritinib d3 Supplier

Gilteritinib d3 Distributor

Gilteritinib d3 for Method Validation

Gilteritinib Reference Standard

Gilteritinib d3 for ANDA Filing

Gilteritinib d3 for Forced Degradation Studies

Gilteritinib d3 Identification Standards

Gilteritinib d3 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,